NOVONIX Balance Sheet Health
Financial Health criteria checks 3/6
NOVONIX has a total shareholder equity of $158.1M and total debt of $64.6M, which brings its debt-to-equity ratio to 40.9%. Its total assets and total liabilities are $240.8M and $82.8M respectively.
Key information
40.9%
Debt to equity ratio
US$64.59m
Debt
| Interest coverage ratio | n/a |
| Cash | US$47.13m |
| Equity | US$158.07m |
| Total liabilities | US$82.77m |
| Total assets | US$240.84m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: NVNX.F's short term assets ($57.9M) exceed its short term liabilities ($9.4M).
Long Term Liabilities: NVNX.F's short term assets ($57.9M) do not cover its long term liabilities ($73.4M).
Debt to Equity History and Analysis
Debt Level: NVNX.F's net debt to equity ratio (11%) is considered satisfactory.
Reducing Debt: NVNX.F's debt to equity ratio has reduced from 108.8% to 40.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NVNX.F has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: NVNX.F has less than a year of cash runway if free cash flow continues to reduce at historical rates of 40.4% each year